Premier Inc. has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital in a deal valued at approximately $2.6 billion.

The Charlotte, North Carolina-based healthcare improvement company will become privately held upon completion of the transaction, which is expected to close in early 2026.

Under the terms of the agreement, Premier stockholders will receive $28.25 per share in cash. The price reflects a 23.8% premium over the company’s 60-day volume-weighted average share price as of Sept. 5, 2025.
“The Board unanimously approved this transaction, after careful consideration of a wide range of strategic alternatives in recent years and consultation with our financial and legal advisors,” said Richard Statuto, board chair at Premier. “We believe this transaction is in the best interests of Premier and its stockholders.”

Premier president and CEO Michael Alkire noted that the move to private ownership would provide additional flexibility and capital to support the company’s technology development and service expansion. “Now, as the healthcare landscape continues to rapidly evolve, transitioning to private ownership will once again enhance the Company’s financial flexibility,” Alkire said.

Founded in 2013, Premier provides analytics, supply chain solutions, and consulting services to healthcare providers across the U.S.

Patient Square Capital is a healthcare-focused investment firm with more than $14 billion in assets under management. “Our team sees tremendous opportunity for Premier to continue growing its differentiated portfolio,” said Dr. Neel Varshney, a founding partner at Patient Square.

The deal is subject to shareholder and regulatory approvals and is not contingent on financing. Premier will suspend its quarterly dividend payments going forward. The company’s stock will be delisted upon transaction close.

U.S. Healthcare Homepage